Smartest Technologies
SmartTest offers painless, automated capillary blood testing, starting with glucose for home diagnos
Company Overview
Snapshot
Founded in April 2023 by David Weintraub, Smartest Technologies operated with 1–10 employees. The company secured $500,000 in its single funding round, a Seed round. The company ceased operations in August 2026.
Business overview
Smartest Technologies developed a comprehensive digital health platform for at-home blood testing, initially focusing on glucose monitoring for the prediabetes market. Their core product, Smart-AE, was an automated, wireless glucose testing device designed to provide painless, accurate, and real-time results. The platform integrated with a mobile app for data transmission, personalized health insights, and remote monitoring. While starting with glucose, the company aimed to expand its platform to include tests for lactate, cholesterol, and infectious diseases, serving the healthcare and life sciences sectors, particularly patients in the medical devices and medical monitors categories.
Company Intelligence Q&A
- What is the current operational status of Smartest Technologies?
- Smartest Technologies ceased to operate in August 2026.
- When was Smartest Technologies founded?
- Smartest Technologies was founded in April 2023.
- Who is a founder of Smartest Technologies?
- David Weintraub is a founder of Smartest Technologies.
- What was the total capital raised by Smartest Technologies?
- Smartest Technologies raised $500,000 across one funding round.
- What was Smartest Technologies' primary product?
- Smartest Technologies' primary product was Smart-AE, an automated, wireless glucose testing device for at-home blood testing.